Publicação
Equity research report: Johnson & Johnson: a legacy of innovation and steady growth
| datacite.subject.fos | Ciências Sociais::Economia e Gestão | pt_PT |
| dc.contributor.advisor | André, Rosário | |
| dc.contributor.author | Jacob, Justin | |
| dc.date.accessioned | 2025-04-02T13:28:59Z | |
| dc.date.available | 2025-04-02T13:28:59Z | |
| dc.date.issued | 2025-01-24 | |
| dc.date.submitted | 2025-01-24 | |
| dc.description.abstract | This equity research report, prepared as part of Nova SBE’s Field Lab by Justin Jacob and Rupert Schuler, evaluates Johnson & Johnson (JNJ). Our valuation estimates a share price of $183, indicating the stock is undervalued compared to its December 13, 2024 market price of $146.62. A detailed relative valuation and sensitivity analysis across four scenarios support this conclusion. The report considers JNJ’s operational resilience, ongoing litigations, and macroeconomic factors, providing a balanced assessment of internal and external influences on the company’s intrinsic value. | pt_PT |
| dc.identifier.tid | 203926404 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10362/181869 | |
| dc.language.iso | eng | pt_PT |
| dc.relation | UID/ECO/00124/2013 | pt_PT |
| dc.subject | Drugs | pt_PT |
| dc.subject | Research & Development | pt_PT |
| dc.subject | Valuation | pt_PT |
| dc.subject | Litigations | pt_PT |
| dc.title | Equity research report: Johnson & Johnson: a legacy of innovation and steady growth | pt_PT |
| dc.type | master thesis | |
| dspace.entity.type | Publication | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | masterThesis | pt_PT |
| thesis.degree.name | A Work Project, presented as part of the requirements for the Award of a Master Degree in Economics / Finance / Management from the NOVA – School of Business and Economics | pt_PT |